Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and cause of anovulatory infertility among reproductive aged women. According to the revised criteria of 2003, four distinct phenotypes of PCOS can be diagnosed. However, there are emerging evidence supporting the existence of different levels of cardiometabolic risk between the four phenotypic groups of the syndrome. The purpose of this study is to determine the cardiovascular risk of i) normoweight and ii)overweight plus obese women of every one of the four phenotypes of the syndrome as well as the levels of low inflammation serum markers and the possible correlations of the between the outcomes.
Study Type
OBSERVATIONAL
Enrollment
300
Second Department of Obstetrics and Gynecology, Third Department of Cardiology, Second Propedeutic Department of Internal Medicine, Aristotle University
Thessaloniki, Greece
high sensitivity C-Reactive Protein (hsC-RP) levels and differences between the phenotypes
Time frame: 1 hour
Lipoprotein-associated phospholipase2 (Lp-PLA2) levels and differences between the phenotypes
Time frame: 1 hour
Cardiovascular Risk Assessment and differences between the phenotypes
Time frame: 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.